Santen Pharmaceutical Co. Ltd. announced the appointment of Sadatoshi Furukado as Director, Vice President and Executive Corporate Officer of Japan Business and Human Resources Development from Director, Executive Corporate Officer of Japan Business and Human Resources Development and Head of Sales and Marketing Division, Prescription Pharmaceuticals; Masamichi Sato as Senior Corporate Officer, Head of Santen European Group and President of Santen Holdings EU B.V. from Senior Corporate Officer, Head of Santen European Group and President of Santen Holdings EU B.V.; Takeshi Ito as Senior Corporate Officer of Head of Sales and Marketing Division, Prescription Pharmaceuticals from Corporate Officer, Head of Prescription of Pharmaceuticals Sales Dept., Sales and Marketing Division of Prescription Pharmaceuticals; Kenji Morishima as Corporate Officer and Head of Global Pharmaceutical Technology Development from Corporate Officer and Head of Human Resources Development and CSR Division; Atsutoshi Ota as Corporate Officer and Head of Human Resources Development and CSR Division from Corporate Officer and Head of Product Supply Division; Kazuo Koshiji as Corporate Officer, Chief Financial Officer and Head of Finance and Administration Division from Corporate Officer and Head of Finance and Administration Division; Noriaki Yamamoto as Corporate Officer, Chief Information Officer and Head of Information Systems Division from Head of Information Systems Division; Hiroyuki Yamazaki as Corporate Officer, Head of Prescription Pharmaceuticals Sales Dept., Sales and Marketing Division, Prescription Pharmaceuticals from Area Manager, Chubu Area, Prescription Pharmaceuticals Sales Dept., Sales and Marketing Division, Prescription Pharmaceuticals; and Keizo Nakada as Corporate Officer and Head of Product Supply Division from Head of Manufacturing Department.
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.